Ghent University Academic Bibliography

Journal Article
A1
open access

Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response

Anna Molto, Desiree van der Heijde, Filip Van den Bosch (UGent) and Maxime Dougados

(2023) ANNALS OF THE RHEUMATIC DISEASES. 82(7).

Miscellaneous

Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

Désirée van der Heijde, Anna Molto, Sofia Ramiro, Jürgen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert D Inman, Robert B M Landewé, Helena Marzo-Ortega, et al.

(2023) Annals of the Rheumatic Diseases. p.ard-2023

Add to list

Journal Article
A1
open access

Safety and efficacy of upadacitinib in patients with active ankylosing spondylitis and an inadequate response to nonsteroidal antiinflammatory drug therapy : one-year results of a double-blind, placebo-controlled study and open-label extension

A Deodhar, D van der Heijde, J Sieper, Filip Van den Bosch (UGent) , WP Maksymowych, TH Kim, M Kishimoto, A Ostor, B Combe, Y Sui, et al.

(2022) ARTHRITIS & RHEUMATOLOGY. 74(1). p.70-80

Add to list

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis

Uta Kiltz, Annelies Boonen, Désirée van der Heijde, Wilson Bautista-Molano, Ruben Burgos Vargas, Praveena Chiowchanwisawakit, Bassel El-Zorkany, Inna Gaydukova, Pal Geher, Laure Gossec, et al.

(2022) RHEUMATOLOGY. 61(5). p.2054-2062

Add to list

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

Atul Deodhar, Filip Van den Bosch (UGent) , Denis Poddubnyy, Walter P Maksymowych, Désirée van der Heijde, Tae-Hwan Kim, Mitsumasa Kishimoto, Ricardo Blanco, Yuanyuan Duan, Yihan Li, et al.

(2022) LANCET. 400(10349). p.369-379

Add to list

Journal Article
A1
open access

Upadacitinib in active ankylosing spondylitis : results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Desiree van der Heijde, Atul Deodhar, Walter P. Maksymowych, Joachim Sieper, Filip Van den Bosch (UGent) , Tae-Hwan Kim, Mitsumasa Kishimoto, Andrew J. Ostor, Bernard Combe, Yunxia Sui, et al.

(2022) RMD OPEN. 8(2).

Add to list

Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility

Walter P. Maksymowych, Robert G. Lambert, Xenofon Baraliakos, Ulrich Weber, Pedro M. Machado, Susanne J. Pedersen, Manouk de Hooge (UGent) , Joachim Sieper, Stephanie Wichuk, Denis Poddubnyy, et al.

(2021) RHEUMATOLOGY. 60(10). p.4778-4789

Add to list

Journal Article
A1
open access

Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process

Féline P.B. Kroon, Désirée van der Heijde, Lara J. Maxwell, Dorcas E. Beaton, Abishek Abishek, Francis Berenbaum, Francisco J. Blanco, Philip G. Conaghan, Krysia Dziedzic, Catherine L. Hill, et al.

(2021) SEMINARS IN ARTHRITIS AND RHEUMATISM. 51(6). p.1311-1319

Add to list

Journal Article
A1
open access

Axial involvement in psoriatic arthritis cohort (AXIS) : the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch (UGent) , Jurgen Braun, Laura C. Coates, Vinod Chandran, Torsten Diekhoff, Floris A. van Gaalen, Lianne S. Gensler, Niti Goel, et al.

(2021) THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 13.

Add to list

Journal Article
A1
open access

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Anna Molto, Clementina López-Medina, Filip Van den Bosch (UGent) , Annelies Boonen, Casper Webers, Emanuelle Dernis, Floris A van Gaalen, Martin Soubrier, Pascal Claudepierre, Athan Baillet, et al.

(2021) ANNALS OF THE RHEUMATIC DISEASES. 80(11). p.1436-1444

Academic Bibliography

Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response

Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

Safety and efficacy of upadacitinib in patients with active ankylosing spondylitis and an inadequate response to nonsteroidal antiinflammatory drug therapy : one-year results of a double-blind, placebo-controlled study and open-label extension

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

Upadacitinib in active ankylosing spondylitis : results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility

Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process

Axial involvement in psoriatic arthritis cohort (AXIS) : the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Contents

Support

Contact